- ►nih.gov SR Boyd, D Tan, C Bunce, A Gittos, MH Neale … - British Journal of Ophthalmology, 2002 - bjo.bmj.com Background: Improved local treatment of uveal melanoma makes it possible for
many patients to retain the affected eye, but a proportion will develop
secondary complications such as neovascularisation of the iris (NVI) and ... Cited by 27 - Related articles - BL Direct - All 7 versions
GSO Missotten, IC Notting, RO Schlingemann, … - Archives of ophthalmology, 2006 - archopht.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 12 - Related articles - BL Direct - All 8 versions
- ►nih.gov [PDF] - Free from Publisher TG Sheidow, PL Hooper, C Crukley, J Young, … - British Journal of Ophthalmology, 2000 - bjo.bmj.com METHODS 47 cases of ciliochoroidal melanoma enucleated between 1983 and 1993
were retrieved from the pathology archives at the University of Western Ontario.
Paraffin sections stained with haematoxylin and eosin, periodic acid ... Cited by 32 - Related articles - BL Direct - All 7 versions
- ►nih.gov SR Boyd, DSW Tan, L de Souza, MH Neale, NE … - British Journal of Ophthalmology, 2002 - bjo.bmj.com Results: While most tumour cells expressed bFGF at the protein level by
immunohistochemistry (89%), relatively few (22%) expressed VEGF, and this was of
limited extent. All 20 tumours tested by RT-PCR contained mRNA for both ... Cited by 29 - Related articles - BL Direct - All 7 versions
SAJ Ijland, MJ Jager, BM Heijdra, JR … - Melanoma Research, 1999 - journals.lww.com Dissemination of uveal melanomas is almost exclusively haematogenous, making
angiogenesis of the tumour a prerequisite for the formation of metastases. Uveal
melanomas must employ strategies to evade the immune system in order to ... Cited by 43 - Related articles - BL Direct - All 2 versions
N Horgan, CL Shields, A Mashayekhi, LF … - Retina, 2008 - pdfs.journals.lww.com From the Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson
University, Philadelphia, Pennsylvania. Supported by The Irish College of
Ophthalmologists/Pfizer Fel- lowship 2005, Dublin, Ireland (NH); The Royal ... Cited by 4 - Related articles - BL Direct - All 3 versions
G Nareyeck, M Zeschnigk, D von der Haar, H … - Ophthalmic Res, 2005 - content.karger.com Based on gene profiling, two entities of uveal melanomas exist. So far, these
two entities can be distinguished by the chromosome 3 status which strongly
associates with the metastatic potential of the tumours. Reorganization of ... Cited by 4 - Related articles - All 5 versions
Y El-Shabrawi, N Ardjomand, H Radner - The Journal of Pathology, 2001 - ingentaconnect.com MMP-9 is predominantly expressed in epithelioid and not ... Y. El-Shabrawi 1 *,
Neda Ardjomand 1 , H. Radner 2 and N. Ardjomand 1 ... 1 Department of
Ophthalmology, Karl-Franzens-University Graz, Austria 2 Department of ... Cited by 30 - Related articles - BL Direct - All 6 versions
- ►iovs.org P Parrella, OL Caballero, D Sidransky, SL … - Investigative ophthalmology & visual science, 2001 - ARVO 1 From the Dipartimento Ricerca BioMedica, Section for Molecular Medicine and
Gene Therapy, University Campus Bio Medico, Rome, Italy; 2 Department of
Otolaryngology—Head and Neck Surgery, Division of Head and Neck Cancer ... Cited by 30 - Related articles - BL Direct - All 5 versions
AW Stitt, DAC Simpson, C Boocock, TA … - The Journal of Pathology, 1998 - interscience.wiley.com The immunolocalization and gene expression of vascular endothelial growth factor
(VEGF) and its cognate tyrosine kinase receptors, Flt-1 and KDR, has been
studied in ocular melanomas and retinoblastomas using in situ hybridization ... Cited by 64 - Related articles - BL Direct - All 3 versions
